The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
Matthew Chow, Michelle CaoDepartment of Psychiatry and Behavioral Sciences, Division of Sleep Medicine, Stanford University School of Medicine, Stanford, CA, USAAbstract: Much of the understanding of the hypocretin/orexin (HCRT/OX) system in sleep–wake regulation came from narcolepsy&n...
Guardado en:
Autores principales: | Chow M, Cao M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9ea979a6e34b4fcc82cf24d3e98d2304 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman JL, et al.
Publicado: (2016) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
por: Vellieux G, et al.
Publicado: (2021) -
Tumor cell apoptosis mediated by the orexins
por: A. S. Diatlova, et al.
Publicado: (2021) -
Research progress on the mechanism of orexin in pain regulation in different brain regions
por: Kang Xianhui, et al.
Publicado: (2021) -
Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson's disease
por: Bridoux A, et al.
Publicado: (2013)